NDC 0143-9366-01 - Labetalol HCl in Sodium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9366
- Requested NDC
- 0143-9366-01
- Package NDCs from labels
- 0143-9366-01, 0143-9366-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2025-12-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Labetalol HCl in Sodium Chloride - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2025-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9366-01 | Labetalol HCl in Dextrose | 200 mL in 1 BAG | INJECTION | 200 | 9 | |
| 0143-9366-10 | Labetalol HCl in Dextrose | 10 in 1 BOX | INJECTION | 10 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0143-9366 | LABETALOL HCL IN SODIUM CHLORIDE (LABETALOL HYDROCHLORIDE) INJECTION LABETALOL HCL IN DEXTROSE (LABETALOL HYDROCHLORIDE) INJECTION LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 8 | Current NDC, Legacy NDC, 2 package rows | 20250131_99a715a0-4579-410c-b102-7ef6fab8db55.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9366-01 | ML - Milliliter | 0143-9366 | dc2c5df0-e7bd-4967-b443-84f81a0ef799 | 1 | 2021-05-05 |
| 0143-9366-10 | ML - Milliliter | 0143-9366 | 5f5ff719-8e9d-42b4-9c51-854907e51578 | 1 | 2021-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIVER PLUS Formula | ADENOSINE TRIPHOSPHATE, IGNATIA AMARA, KALI PHOSPHORICUM, NATRUM MURIATICUM, NUX VOMICA, SULPHUR | Apex Energetics Inc. | d8c7b349-8718-d8ed-e053-2995a90ae988 | 2024-01-08 | Warnings | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 037ac04d-f8f3-4bb8-993a-ac8f7683ff83 | 2024-01-04 | Warnings, Adverse reactions | 451W47IQ8X |
| Sinus HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA, THUJA OCCIDENTALIS | Energique, Inc. | 3cdddbe5-e3d2-4629-a045-868e18183f1d | 2023-12-19 | Warnings | 451W47IQ8X |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Altachlore Sodium Chloride Hypertonicity | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | dc0d94d8-4475-4956-8ded-bdb9496074e4 | 2023-12-09 | Warnings | 451W47IQ8X |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| terrasil Eczema and Psoriasis Severe Outbreak | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | 4d7128fb-57f1-4d0d-a83a-daef40928ecd | 2023-11-30 | Warnings | 451W47IQ8X |
| terragen HG Formula Maximum Strength | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | e632c831-e25d-4d04-ba72-2327d25713b1 | 2023-11-30 | Warnings | 451W47IQ8X |
| Femstat C | ECHINACEA (ANGUSTIFOLIA), FUCUS VESICULOSUS, HYDRASTIS CANADENSIS, PHYTOLACCA DECANDRA, KREOSOTUM, NATRUM MURIATICUM, CANDIDA ALBICANS, LYCOPODIUM CLAVATUM, PULSATILLA (PRATENSIS), SEPIA | Energique, Inc. | 420119ca-f2bf-40e3-9e40-00498724c228 | 2023-11-30 | Warnings | 451W47IQ8X |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Endopar | GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, OOPHORINUM (SUIS), ORCHITINUM (BOVINE), PINEAL GLAND, THYROIDINUM, ARSENICUM ALBUM, BARYTA CARBONICA, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PULSATILLA (PRATENSIS) | Energique, Inc. | 06375c3e-cc05-4450-9117-1d3dc72636eb | 2023-11-21 | Warnings | 451W47IQ8X |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8646d7ea-cf5e-607d-e053-2a91aa0aeca1 | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86466121-7217-d053-e053-2a91aa0a8f8a | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 864669c9-5bdc-232f-e053-2a91aa0a1fc6 | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86462e06-d221-36b7-e053-2991aa0a1d82 | 2023-11-14 | 451W47IQ8X | |
| Mineffect nasal mist | CALCAREA SILICATA, SILICEA, SULPHUR, NATRUM MURIATICUM, FERRUM METALLICUM, FERRUM PHOSPHORICUM, PHOSPHORUS, FERRUM MURIATICUM, TITANIUM METALLICUM, | Kadesh Incoporation Co,Ltd | 3a29bf95-a8a3-4517-aedf-0cd4a91b349c | 2023-10-31 | Warnings | 451W47IQ8X |
| Insomnia | AQUILEGIA VULGARIS, AVENA SATIVA, CHAMOMILLA, COFFEA CRUDA, CYPRIPEDIUM PUBESCENS, HUMULUS LUPULUS, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, MELATONIN, MELISSA OFFICINALIS, NATRUM MURIATICUM, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS | Liddell Laboratories, Inc. | 18c15f17-1a16-4595-9d23-20353363cd72 | 2023-10-31 | Warnings | 451W47IQ8X |
| Labetalol hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 83a6e770-207a-46bc-992d-c1ad90d1006d | 2023-10-30 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 1a71964e-e6fa-443e-bfdd-f8852f8cf29e | 2023-10-26 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Saline | NASAL | GERI-CARE PHARMACEUTICAL CORP | d293cc13-4043-0d58-e053-2995a90a3fbc | 2023-10-24 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.